Non-Interventional Postmarketing Safety Study to Evaluate the COMIRNATY 2024-2025 Formula (monovalent KP.2) in the United States

21/02/2025
28/05/2026
EU PAS number:
EUPAS1000000476
Study
Ongoing
Documents
Study protocol
Initial protocol
English (1.27 MB - PDF) View document
Updated protocol
English (1.19 MB - PDF) View document
Study results
Study report
Other information